In AD specifically, we previously demonstrated that infusion of an SCD inhibitor into the brain’s lateral ventricles decreased local MUFA build up and resulted in reversal of core biological features of AD, including microglial activation, hippocampal dendritic spine loss, and learning and memory impairments15,25. The gene discussed is SCD; the disease is Alzheimer disease.